Logo image of OM

OUTSET MEDICAL INC (OM) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:OM - US6901452069 - Common Stock

3.71 USD
+0.09 (+2.49%)
Last: 12/31/2025, 8:22:16 PM
3.7 USD
-0.01 (-0.27%)
After Hours: 12/31/2025, 8:22:16 PM

OM Key Statistics, Chart & Performance

Key Statistics
Market Cap67.34M
Revenue(TTM)120.07M
Net Income(TTM)-88.16M
Shares18.15M
Float16.84M
52 Week High25.35
52 Week Low3.1
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-10.32
PEN/A
Fwd PEN/A
Earnings (Next)01-05 2026-01-05/amc
IPO2020-09-15
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


OM short term performance overview.The bars show the price performance of OM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60 -80

OM long term performance overview.The bars show the price performance of OM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of OM is 3.71 USD. In the past month the price decreased by -8.4%. In the past year, price decreased by -82.33%.

OUTSET MEDICAL INC / OM Daily stock chart

OM Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.11 217.86B
ISRG INTUITIVE SURGICAL INC 65.78 200.77B
BSX BOSTON SCIENTIFIC CORP 32.32 141.35B
SYK STRYKER CORP 26.69 134.41B
BDX BECTON DICKINSON AND CO 13.46 55.39B
IDXX IDEXX LABORATORIES INC 53.65 54.02B
EW EDWARDS LIFESCIENCES CORP 33.17 49.47B
GEHC GE HEALTHCARE TECHNOLOGY 17.87 37.36B
RMD RESMED INC 24.33 35.16B
DXCM DEXCOM INC 35.68 25.89B
PODD INSULET CORP 62.2 20.00B
ZBH ZIMMER BIOMET HOLDINGS INC 11.11 17.82B

About OM

Company Profile

OM logo image Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 354 full-time employees. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

Company Info

OUTSET MEDICAL INC

3052 Orchard Drive

San Jose CALIFORNIA 95134 US

CEO: Leslie Trigg

Employees: 354

OM Company Website

OM Investor Relations

Phone: 16692318200

OUTSET MEDICAL INC / OM FAQ

What does OM do?

Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 354 full-time employees. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.


Can you provide the latest stock price for OUTSET MEDICAL INC?

The current stock price of OM is 3.71 USD. The price increased by 2.49% in the last trading session.


Does OUTSET MEDICAL INC pay dividends?

OM does not pay a dividend.


What is the ChartMill rating of OUTSET MEDICAL INC stock?

OM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the number of employees for OUTSET MEDICAL INC?

OUTSET MEDICAL INC (OM) currently has 354 employees.


What is the market capitalization of OM stock?

OUTSET MEDICAL INC (OM) has a market capitalization of 67.34M USD. This makes OM a Micro Cap stock.


What is the Short Interest ratio of OUTSET MEDICAL INC (OM) stock?

The outstanding short interest for OUTSET MEDICAL INC (OM) is 13.19% of its float.


OM Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

OM Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to OM. Both the profitability and financial health of OM have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OM Financial Highlights

Over the last trailing twelve months OM reported a non-GAAP Earnings per Share(EPS) of -10.32. The EPS increased by 65.94% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -31.8%
ROE -61.93%
Debt/Equity 0.67
Chartmill High Growth Momentum
EPS Q2Q%88.21%
Sales Q2Q%2.67%
EPS 1Y (TTM)65.94%
Revenue 1Y (TTM)4.65%

OM Forecast & Estimates

13 analysts have analysed OM and the average price target is 16.07 USD. This implies a price increase of 333.02% is expected in the next year compared to the current price of 3.71.

For the next year, analysts expect an EPS growth of 82.99% and a revenue growth 3.61% for OM


Analysts
Analysts83.08
Price Target16.07 (333.15%)
EPS Next Y82.99%
Revenue Next Year3.61%

OM Ownership

Ownership
Inst Owners94.39%
Ins Owners1.87%
Short Float %13.19%
Short Ratio3.88